Nutrien (NYSE:NTR - Get Free Report) had its price objective upped by analysts at Wells Fargo & Company from $56.00 to $59.00 in a research report issued on Monday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Wells Fargo & Company's price objective suggests a potential upside of 5.44% from the company's previous close.
Several other research firms have also recently weighed in on NTR. Royal Bank of Canada increased their price objective on shares of Nutrien from $60.00 to $65.00 and gave the stock an "outperform" rating in a research report on Monday. BNP Paribas raised Nutrien to a "strong-buy" rating in a research report on Wednesday, April 9th. UBS Group boosted their price objective on Nutrien from $52.00 to $56.00 and gave the company a "neutral" rating in a research note on Thursday. Oppenheimer decreased their target price on Nutrien from $60.00 to $58.00 and set an "outperform" rating for the company in a research note on Tuesday, April 22nd. Finally, CIBC boosted their price target on Nutrien from $64.00 to $66.00 and gave the company an "outperformer" rating in a research note on Tuesday, February 25th. Two analysts have rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $60.87.
View Our Latest Report on Nutrien
Nutrien Price Performance
Shares of NYSE NTR traded up $0.33 during midday trading on Monday, reaching $55.96. 1,263,966 shares of the company were exchanged, compared to its average volume of 2,125,675. Nutrien has a one year low of $43.70 and a one year high of $60.87. The stock's 50-day moving average price is $51.97 and its 200-day moving average price is $49.98. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The stock has a market cap of $27.32 billion, a P/E ratio of 40.82, a PEG ratio of 1.19 and a beta of 0.79.
Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.24). Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The company had revenue of $4.67 billion during the quarter, compared to analyst estimates of $5.16 billion. During the same period in the previous year, the company posted $0.46 EPS. The company's quarterly revenue was down 5.4% on a year-over-year basis. On average, sell-side analysts anticipate that Nutrien will post 3.72 earnings per share for the current fiscal year.
Institutional Trading of Nutrien
A number of hedge funds have recently bought and sold shares of the business. Fairway Wealth LLC purchased a new stake in Nutrien during the fourth quarter worth about $27,000. HHM Wealth Advisors LLC raised its holdings in shares of Nutrien by 331.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 625 shares of the company's stock worth $28,000 after purchasing an additional 480 shares during the period. Assetmark Inc. lifted its stake in Nutrien by 1,437.5% in the fourth quarter. Assetmark Inc. now owns 738 shares of the company's stock valued at $33,000 after purchasing an additional 690 shares during the last quarter. Asset Planning Inc bought a new position in Nutrien during the fourth quarter valued at $35,000. Finally, Harbour Investments Inc. increased its position in Nutrien by 94.8% in the first quarter. Harbour Investments Inc. now owns 715 shares of the company's stock worth $35,000 after buying an additional 348 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors.
About Nutrien
(
Get Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.